1Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation, 2004, 110: 1514-1517.
2Shlipak MG. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med, 2003, 138: 917-924.
3Dries DL, Exner DV, Domanski MJ, et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol, 2000, 35: 681-689.
4Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation, 2000, 102: 203-210.
5Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail, 2003, 9: 13-25.
6McAlister FA, Ezekowitz J, Tonelli M, et al. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation, 2004, 109: 1004-1009.
7Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol, 2004, 43: 61-67.
8Boerrigter GC, Burnett Jr JC. Cardiorenal Syndrome in Decompensated Heart Failure: Prognostic and Therapeutic Implications. Heart Failure Reports, 2004, 1: 113-120.
9Neumann J, Ligtenberg G, Klein II, et al. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int, 2004, 65: 1568-1576.
10Silverberg DS, Wexler D, Blum M, et al. The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome. Blood Purif, 2004, 22: 277-284.
